AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elekta

Report Publication Announcement Nov 17, 2015

2906_rns_2015-11-17_fed85c81-54db-4a7b-98e8-dc0d04a4c721.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Conference call regarding Elekta's interim report for May-October 2015/16

STOCKHOLM, November 17 – Elekta (EKTA-B.ST) will publish its interim report for May-October 2015/16 on December 4, as per:

  • The report will be published at 07:30 CET.
  • Elekta will host a telephone conference at 10:00-11:00 CET with Tomas Puusepp, President and CEO and Håkan Bergström, CFO.

To take part in the conference call, please dial in about five minutes in advance.

  • UK dial-in number: +44 (0) 203 428 14 09
  • US dial-in number: +1 855 753 22 36
  • Swedish dial-in number: +46 (0)8 566 426 64

The telephone conference will also be broadcasted live online, through the following link (however, please call in also in order to ask questions):

http://event.onlineseminarsolutions.com/r.htm?e=1096935&s=1&k=195FCFCFA7C622F68F0 4F81204962886

#

For further information, please contact:

Johan Andersson, Director Investor Relations, Elekta AB. Tel: +46 702 100 451, e-mail: [email protected] Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: [email protected] Time zone: CET: Central European Time

Frida Johansson, Investor Relations Coordinator, Elekta AB Tel: +46 708 667 674, e-mail: [email protected] Time zone: CET: Central European Time

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resourceefficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.